Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...
Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good morning and welcome to Ocugen’s Third Quarter 2024 Financial ...
Ocugen ( OCGN -6.48%) Q3 2024 Earnings Call Nov 08, 2024, 8:30 a.m. ET Good morning and welcome to Ocugen's third quarter 2024 financial results and business update. [Operator instructions] I will now ...
In 1999, Kevin Byrne, a West Point graduate, was 27 years old in the army in Korea serving as a Captain and an Air Cavalry ...
In an evolving wellness landscape, Massages Me stands at the forefront of change in the UK’s massage therapy sector. We sat ...
New Yorkers seeking to unburden themselves after last week's election got a chance to share their feelings by posting sticky notes in a ...
Set on building a mass movement for change, Rivon4 urges Israelis from all sectors to imagine -- and act for -- a united ...
In March 2013, the government-run drug rehab Hanoi released Hung Quang Pham early. They didn’t want the bone-thin heroin user ...
Good morning and welcome to Agenus' third quarter 2024 conference call and webcast. All participants will be in a listen-only ...
In the ever-evolving landscape of modern parenting, few stories resonate as deeply as that of Amy Aquilini. Recently ...
Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good morning, ladies and gentlemen, and welcome to Fennec ...
Good morning, and welcome to the Axsome Therapeutics Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, there will be a question and ...